These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34641931)

  • 21. A rare cause of postmenopausal hyperandrogenism.
    De Vis M; Brock S; Cosyns S; Velkeniers B
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33414114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian steroid cell tumors: sonographic characteristics.
    Monteagudo A; Heller D; Husami N; Levine RU; McCaffrey R; Timor-Tritsch IE
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):282-8. PubMed ID: 9383882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
    Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
    Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
    Palha A; Cortez L; Tavares AP; Agapito A
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison.
    Chen H; Liu Y; Shen LF; Jiang MJ; Yang ZF; Fang GP
    J Ovarian Res; 2016 Nov; 9(1):81. PubMed ID: 27876070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging in gynecological disease (23): clinical and ultrasound characteristics of ovarian carcinosarcoma.
    Ciccarone F; Biscione A; Moro F; Fischerova D; Savelli L; Munaretto M; Jokubkiene L; Sladkevicius P; Chiappa V; Fruscio R; Franchi D; Epstein E; Timmerman D; Froyman W; Valentin L; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):241-247. PubMed ID: 34225386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center.
    Moro F; Mascilini F; Pasciuto T; Leombroni M; Li Destri M; De Blasis I; Garofalo S; Scambia G; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1182-1194. PubMed ID: 31326950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignancy risk of sonographically benign appearing purely solid adnexal masses in asymptomatic postmenopausal women.
    Alcazar JL; Pascual MA; Marquez R; Ajossa S; Juez L; Graupera B; Piras A; Hereter L; Guerriero S
    Menopause; 2017 Jun; 24(6):613-616. PubMed ID: 28118296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.
    Valentin L; Ameye L; Franchi D; Guerriero S; Jurkovic D; Savelli L; Fischerova D; Lissoni A; Van Holsbeke C; Fruscio R; Van Huffel S; Testa A; Timmerman D
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):80-9. PubMed ID: 23001924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virilizing tumors of the ovary: imaging features.
    Outwater EK; Marchetto B; Wagner BJ
    Ultrasound Obstet Gynecol; 2000 May; 15(5):365-71. PubMed ID: 10976475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative sonographic features of borderline ovarian tumors.
    Exacoustos C; Romanini ME; Rinaldo D; Amoroso C; Szabolcs B; Zupi E; Arduini D
    Ultrasound Obstet Gynecol; 2005 Jan; 25(1):50-9. PubMed ID: 15619309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
    Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
    BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new sonomorphologic scoring-system (Mainz score) for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: A comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women.
    Weber G; Merz E; Bahlmann F; Leber AM
    Ultraschall Med; 1999 Feb; 20(1):2-8. PubMed ID: 10226339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of ovarian tumors in postmenopausal women by transvaginal sonography.
    Osmers RG; Osmers M; von Maydell B; Wagner B; Kuhn W
    Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):81-8. PubMed ID: 9550206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
    Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
    Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
    Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
    Bahaeldein E; Brassill MJ
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal Hyperandrogenism Associated With Synchronous Ovarian Brenner Tumor, Bilateral Leydig Cell Tumor, and Adrenal Mass.
    Salim M; Dasaraju S; Erickson B; Khalifa M; Burmeister LA
    Cureus; 2024 Mar; 16(3):e55334. PubMed ID: 38559537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.